The present invention relates to devices, systems and methods for positioning an electrical lead in a patient's body.
Spinal cord stimulation (SCS) has been used to treat a wide variety of disorders including chronic pain, phantom limb pain, ischemic limb pain, and pain after failed spinal surgery. Physicians routinely use two different SCS systems: those involving percutaneously placed electrical leads and those requiring laminectomies to allow placement of an electrical lead. The first system involves percutaneous insertion of an electrical lead into the epidural space and either transcutaneous connection to an external generator, allowing a trial period of stimulation, or subcutaneous connection to an implanted radio frequency-controlled receiver or an implantable pulse generator. The second system requires implantation of a paddle-type electrical lead into the epidural space after a laminectomy. Similar to percutaneously placed lead, the electrical paddle-type lead may be connected to an external generator, allowing a trial period of stimulation, or may be connected subcutaneously to a radio frequency receiver or an implantable pulse generator. The radio frequency receiver is activated by an external battery-powered transmitter, which operates through an antenna placed over the receiver. The implantable pulse generator contains a battery that supplies power to the electrodes of the lead. (See Tracy Cameron, “Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20 year literature review,” J. Neurosurg (Spine 3), 100:254-267 (2004)).
The exact anatomical location of SCS lead placement depends on the location of the painful region. SCS leads have been placed in locations from C-1 to L-5 to treat pain of the trunk and/or limb. To achieve optimal pain relief effects, stimulation paresthesias should cover the area of pain. (See Cameron, page 254). As such, it is important that the electrodes of the electrical lead be properly positioned in the spinal canal in order to achieve optimal therapeutic benefits.
The present invention provides systems, devices and methods for positioning a lead at a target site in a patient's body. For example, in certain embodiments, the present invention provides a positioning device that is separate or integral with an electrical lead to assist in lead positioning and to urge electrodes of the electrical lead towards the therapy site. In a preferred embodiment, the positioning device is a separate device that is added to an electrical lead by a user prior to insertion of the lead in the patient's body. In other embodiments, the device is integrated into the structure of the lead. Although the positioning device is described herein with references to a percutaneous SCS lead, the positioning device can be used with other leads such as paddle-style leads or irregularly shaped leads. Additionally, a positioning device can be used for leads and catheters that are not designed for use in SCS, such as, for example, deep brain leads, gastric leads, vagus nerve or other cranial nerve leads, intradural leads, spinal nerve leads, peripheral leads, and drug delivery catheters.
In a preferred embodiment, a positioning device comprises arms, such as axial protrusions, extending from the body of an electrical lead. The arms are flexible enough to fold against the lead body during passage through a needle or other delivery device to the target site and not cause damage to tissue, such as spinal tissue. However, the arms are stiff enough to offer resistance to tissue surrounding the target site such as surrounding tissue in the epidural space. In a preferred embodiment, the angle between each of the arms and the longitudinal axis of the lead body or a hub disposed about the lead body (as described below) is greater than 100 degrees. This assists with passage through a touhy-style needle, which is the popular insertion method for SCS percutaneous leads, as well as forward passage into the epidural space. Such an angle also adds anchoring ability and resistance to backward movement of the lead assembly. In certain embodiments, the arms provide greater resistance in one direction of movement than the other. For example, the lead can be easy to push forward to the desired target because the arms move more easily against the lead body. However, when the lead is retracted or pulled, the arms offer greater resistance. In a preferred embodiment, a positioning device offers greater resistance to pulling, but not a resistance that is so high it cannot be overcome or would cause damage, if it is desired to remove the lead.
Although a positioning device of the present invention can assist with lead anchoring, a positioning device primarily functions to position the electrodes closer to the target site. In a preferred embodiment, the arms of a positioning device are long enough such that they are at minimum the size of the passage in which a lead is inserted. It may be beneficial for the arms to be longer than that of the passage diameter, as this places more resistance against the passage walls. The arms can be manufactured of any reasonable length, and may be trimmed to an appropriate size as determined by the implanting physician. Alternatively, the arms may be manufactured in various sizes.
Preferably, the electrodes of a SCS lead make intimate contact with the dura. Often, a problem known in the art as “windshield wipering,” occurs when the SCS distal tip moves into the left or right gutter of the spinal cord space. In a preferred embodiment, a positioning device comprises a plurality of arms that protrude in a minimum of three directions. In a preferred embodiment, looking directly at a cross-section of the spinal cord with the dorsal side at zero degrees, two of the three arms oppose each other at approximately 90 and 270 degrees to resist lateral movement of the distal electrodes into the epidural canal or intradural canal. The third arm preferably is positioned at approximately zero degrees to resist dorsal movement and force the electrodes into intimate contact with the dura. The intimate contact and increased stable positioning offers the benefit of lower energy consumption due to decreased electrical resistance, and less changes to optimal stimulation settings due to decrease unintended stimulation and paraesthesia migration. The arms of a positioning device, however, are not limited to three, as there can be more, which allows the arms to provide resistance to lead movement in different directions.
Additionally, the arms of a positioning device may fold back on themselves, or take several different shapes when relaxed into their natural manufactured position. This may offer increased force against the passage walls, thereby increasing anchoring force and resistance to movement. In a preferred embodiment, the arms may still be stretched out along the lead body and keep the lead profile to a maximum outer diameter that would allow passage through an introducing needle.
The positioning device may comprise multiple axial sets of arms located on the distal end of an electrical lead. A minimum of one set may be used, up to multiple sets between axial electrodes and even extending proximally onto the mid-lead body. Again, the arms of a positioning device may be incorporated into the lead structure or added by means of a secondary device at the time of surgery or even beforehand in a secondary manufacturing phase.
In order to keep the arms from applying outward axial force before it is desired, certain embodiments provide for a thin sheath that may be place on the outside diameter of the lead and over the positioning device. Once the lead distal electrodes are in their desired location or past a point where the arms may be extended, the sheath can be retracted by the user, allowing the arms to apply outward axial force. Additionally, the sheath may be a coating or a material that is bioabsorbable such that the arms are exposed over time once implanted.
In a preferred embodiment, the positioning device (whether built into the lead or added at a later point) is radiopaque for visibility by the physician while using fluoroscopy to place the lead. If elastomeric, the positioning device may be loaded with a material such as barium to increase radiopacity. In a preferred embodiment, only part of the positioning device is radiopaque. This allows visualization of the arms under fluoroscopy and would also allow the user to determine rotational orientation if the radiopaque loading or markings are asymmetrical on the lead body. If there are three arms spanning 180° about the lead's outer diameter as described above in a preferred embodiment, there is rotational asymmetry that is desirable to visualize and could be done so by an asymmetrical radiopaque marking such as a dot or tag on only one side of the device.
In embodiments where the arms are part of an addable device that is assembled onto the lead, it is preferable to provide extra holding force to the lead outer diameter. This may be accomplished through features built into the electrical lead design, a suture, adhesive, or by using elastic material such as silicone, polyurethane, or a silicone—polyurethane blend that is undersized to the lead outer diameter so that an interference fit provide holding force between the arms and the electrical lead.
In general, an addable positioning device can have an elastic hub with an inner diameter smaller than the lead's outer diameter. The arms can be fabricated of any suitable biocompatible material, rigid or elastic. In a preferred embodiment, the hub and arms of a positioning device are one device that has been molded from an elastic silicone material. This allows the arms to collapse as the lead assembly is being placed through an introducer such as an implantation device and implanted in its final position.
Regarding particular embodiments of the present invention, in an embodiment, the present invention provides an electrical lead system for positioning an electrical lead at a target site of a patient's body. The system comprises an electrical lead, an electrical conductor and a positioning device. The electrical lead comprises an electrical lead body having a proximal portion with a proximal end, a distal portion with a distal end, and a length between the proximal and distal ends. The length has a longitudinal axis. The electrical lead further comprises an electrode array comprising a plurality of electrodes. The electrode array is located on the distal portion of the lead body. The system further comprises an electrical conductor extending between the proximal portion and the distal portion of the lead body and in electrical communication with the electrode array. The system further comprises
In another embodiment, the present invention provides a method of positioning an electrical lead in a target site of the spinal canal of a patient. The method comprises providing an electrical lead system. The electrical lead system comprises an electrical lead including an electrical lead body having a proximal portion with a proximal end, a distal portion with a distal end, and a length between the proximal and distal ends. The electrical lead also includes an electrode array comprising a plurality of electrodes located on the distal portion of the lead body. The electrical lead system further comprises an electrical conductor extending between the proximal portion and the distal portion of the lead body and in electrical communication with the electrode array. The electrical lead system also includes a positioning device mountable on the lead body. The positioning device comprises at least three arms radiating from the lead body, wherein the angle between at least two of the arms is greater than 120 degrees. The method further comprises using an installation tool to mount a positioning device on the lead body. The method also includes inserting the electrical lead into the patient's body and placing the electrical lead in the patient's spinal canal. The lead can be inserted percutaneously. The plurality of arms of the positioning device extends radially outward away from the lead body and offers resistance to tissue in the spinal canal and directs at least one of the electrodes of the electrode array towards the spinal cord.
The present invention provides systems, devices and methods for positioning a medical device at a target site in a patient's body. In preferred embodiments, the patient is a mammal, such as a human being. In certain embodiments, the medical device delivers a therapy signal to a therapy site in the patient's body. The therapy site can be the same site as the target site or can be adjacent to the target site. The medical device, for example, can be an electrical lead and/or a drug delivery catheter and the therapy signal can be an electrical signal and/or a chemical signal that provides a therapeutic effect to the patient. Although the present invention may be described with respect to SCS where the therapy site is the spinal cord and the target site is the epidural or intradural space of the spinal canal, the present invention can be used for other therapeutic purposes for other parts of a patient's body. For example, the present invention can be used for neuromodulation or other therapies of the brain, including the cortex and specifically the motor cortex; cranial nerves such as the vagus nerve; peripheral nerves such as spinal nerves including the occipital nerve and sacral nerve; and other regions of the nervous system, both the central and peripheral nervous system. The systems, devices, and methods can be used for deep brain leads, gastric leads, vagus nerve leads, peripheral nerve leads including occipital nerve and sacral nerve leads, drug delivery catheters, cardiac catheters, and cardiac stimulation leads.
The disclosure herein may refer to electrical or neural “stimulation” or “modulation.” Such terms include inhibition or activation of electrical activity in and/or around the therapy site. The terms “laterally,” “anteriorly” and “posteriorly” are used herein with respect to the anatomical directions of a human body in a standard anatomical position as is known in the art. The disclosure herein also refers to the term “substantially” with respect to certain geometric shapes and configurations. By “substantially” is meant that the shape or configuration of the described component, feature, or element need not have the mathematically exact described shape or configuration, but can have a shape that is recognizable by one skilled in the art as generally or approximately having the described shape or configuration. Also, the disclosure herein refers to an “operative configuration.” This is the configuration of the system when the medical device has been inserted into the patient and is being steered to the target site. Further, as used herein with respect to a described component, the terms “a,” “an,” and “the” include at least one or more of the described component, feature or element unless otherwise indicated. Moreover, the term “or” includes the term “and/or” unless otherwise indicated. In addition, it will be understood that when an element is referred to as being “on,” “attached” to, “connected” to, “coupled” with, “contacting,” etc., another element, it can be directly on, attached to, connected to, coupled with or contacting the other element or intervening elements may also be present. In contrast, when an element is referred to as being, for example, “directly on,” “directly attached” to, “directly connected” to, “directly coupled” with or “directly contacting” another element, there are no intervening elements present. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.
Referring to
An electrical lead system further comprises an electrical conductor (not shown) extending between the proximal portion and distal portion 16 of lead body 14 or extending from the proximal end and through the distal end 64 in the case of paddle-style lead 60. The electrical conductor is in electrical communication with electrode array 20 of lead 12 or the electrode array of lead 60.
An electrical lead system of the present invention further comprises a positioning device 24 on lead body 14. A positioning device 82 is also on paddle body 68. Although the below disclosure will be described with respect to an exemplary percutaneous lead as depicted in
A positioning device of the present invention can be disposed on the lead body in various locations and an electrical lead system of the present invention can include a plurality of positioning devices. Preferably, a positioning device is positioned on the distal portion of the lead body. Further, as shown in
The at least three arms of a positioning device of the present invention can be directly/integrally coupled to the lead body as shown in
In certain embodiments, each of the arms of a positioning device has a length extending between a free end 42 and an end 43 attached to the lead body or to a hub (as shown in
Referring to
In preferred embodiments, a positioning device is capable of being visualized under fluoroscopy to aid with placement of the positioned device in the spinal canal. For example, radiopaque markings could be incorporated into the positioning device to assist in identification of user-positioned orientation. Such markings include any suitable radiopaque material or impregnation, for example. The markings can be incorporated into the arms and/or hub (if a hub is present) of the positioning device. In other embodiments, markings may be incorporated into an arm that is a different length than the other arms so that a user can determine the direction in which the asymmetrically spaced arm is pointed. In another embodiment, only one arm is impregnated with a radiopaque material, such as barium, so that a user can determine the orientation of the positioning device. Other methods of assisting the user in determining the rotational orientation of the lead and positioning device may be employed.
In certain embodiments, the positioning device is sized to pass through a 14 gauge or greater introducer. Further, in certain embodiments, the system excludes sutures to anchor a positioning device to the lead or to the target site of the patient's body.
Referring to
An exemplary method of using a positioning device will now be described. The method comprises providing an electrical lead system. The electrical lead system comprises an electrical lead including an electrical lead body having a proximal portion with a proximal end, a distal portion with a distal end, and a length between the proximal and distal ends. The electrical lead also includes an electrode array comprising a plurality of electrodes located on the distal portion of the lead body. The electrical lead system further comprises an electrical conductor extending between the proximal portion and the distal portion of the lead body and in electrical communication with the electrode array. The electrical lead system also includes a positioning device mountable on the lead body. The positioning device comprises at least three arms radiating from the lead body, wherein the angle between at least two of the arms is greater than 120 degrees. The method further comprises using an installation tool to mount a positioning device on the lead body. The method also includes inserting the electrical lead into the patient's body and placing the electrical lead in a target site of the patient's spinal canal. The at least three arms of the positioning device extends radially outward away from the lead body and offers resistance to tissue in the spinal canal and directs at least one of the electrodes of the electrode array towards the spinal cord. In certain embodiments, the electrical lead in placed in the patient's epidural space and in other embodiments, the lead is placed in the patient's intradural space.
In other embodiments, the present invention provides methods of controlling the delivery of electrical energy to a therapy site in the body. An exemplary method comprises providing an electrical lead system. The electrical lead system comprises an electrical lead including an electrical lead body having a proximal portion with a proximal end, a distal portion with a distal end, and a length between the proximal and distal ends. The electrical lead also includes an electrode array comprising a plurality of electrodes located on the distal portion of the lead body. The electrical lead system further comprises an electrical conductor extending between the proximal portion and the distal portion of the lead body and in electrical communication with the electrode array. The method further comprises providing an insulating device comprising an insulative body defining an aperture therethrough. The method further comprises inserting the electrical lead and insulating device into the patient's body and placing the insulating device between the therapy site and the electrical lead. The method includes aligning the aperture of the insulating device with the therapy site and activating the electrical lead to deliver electrical energy to the therapy site through the aperture of the insulating device. The separate insulating device used in conjunction with an electrical lead essentially controls where electrical current can pass into nerve tissue such as the spinal cord. As shown in
Referring to
The present invention also provides a fluoroscopic marker system to assist a physician or other health care provider in determining certain features of a implanted medical device, such as where the medical device has been implanted, inserted or advanced; what type of medical device has been implanted, inserted or advanced; the route of insertion; and other information. Referring to
In particular with reference to SCS, first fluoroscopic label 84 can having a marking indicating the spinal segment level at which an electrical lead is implanted into a patient. The back side of the label can be configured for placement on a patient's back. Flouroscopic marker system 83 can also include a second fluoroscopic label 86 corresponding to the route of delivery or method of implantation of the medical device. For example, in the case of SCS, second fluoroscopic label 86 can correspond to either the epidural space or the intradural space. As with label 84, second fluoroscopic label 86 comprises a front side and a back side. The front side comprises a radiopaque marking indicating the route of delivery or method of implantation, such as whether an electrical lead has been implanted in the epidural space or the intradural space of a patient in the case of SCS. The back side is similar to the back side of label 84.
Other fluoroscopic labels can be used as well, such as labels 88 indicating the model number of the medical device, such as the model of the electrical lead, and any accessory devices, such as the model of a generator used to deliver electrical energy to the lead. Referring to
The foregoing description and examples have been set forth merely to illustrate the invention and are not intended as being limiting. Each of the disclosed aspects and embodiments of the present invention may be considered individually or in combination with other aspects, embodiments, and variations of the invention. Further, while certain features of embodiments of the present invention may be shown in only certain figures, such features can be incorporated into other embodiments shown in other figures while remaining within the scope of the present invention. In addition, unless otherwise specified, none of the steps of the methods of the present invention are confined to any particular order of performance. Modifications of the disclosed embodiments incorporating the spirit and substance of the invention may occur to persons skilled in the art and such modifications are within the scope of the present invention. Furthermore, all references cited herein are incorporated by reference in their entirety.
The present application claims priority to U.S. Provisional Application No. 61/622,337 filed on Apr. 10, 2012 entitled: “Systems and Methods for Stimulating the Spinal Cord;” U.S. Provisional Application No. 61,712,517 filed on Oct. 11, 2012 entitled: “Lead Assemblies, Implantation Tools, Accessory Tools, and Systems and Methods of Using Same;” and U.S. Provisional Application No. 61/729,452 filed on Nov. 23, 2012 entitled: “Positioning Elements and Tools for Adding Positioning Elements to Leads and Catheters,” all of which are incorporated by reference herein in their entirety.
Number | Date | Country | |
---|---|---|---|
61622337 | Apr 2012 | US | |
61712517 | Oct 2012 | US | |
61729452 | Nov 2012 | US |